These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28708205)

  • 1. MiR-411 functions as a tumor suppressor in renal cell cancer.
    Zhang X; Zhang M; Cheng J; Lv Z; Wang F; Cai Z
    Int J Biol Markers; 2017 Oct; 32(4):e454-e460. PubMed ID: 28708205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
    Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressive miR-196a is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
    Li Y; Jin L; Chen D; Liu J; Su Z; Yang S; Gui Y; Mao X; Nie G; Lai Y
    Mol Med Rep; 2016 Jul; 14(1):560-6. PubMed ID: 27175581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma.
    Pan X; Quan J; Li Z; Zhao L; Zhou L; Jinling X; Weijie X; Guan X; Li H; Yang S; Gui Y; Lai Y
    Biomed Pharmacother; 2018 Jun; 102():718-727. PubMed ID: 29604591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
    Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
    Li G; Chong T; Xiang X; Yang J; Li H
    Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
    Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
    Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
    Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
    Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
    Pan X; Li Z; Zhao L; Quan J; Zhou L; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Lai Y
    Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-206 inhibits renal cell cancer growth by targeting GAK.
    Wei C; Wang S; Ye ZQ; Chen ZQ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):852-858. PubMed ID: 27924503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated microRNA-16 as an oncogene in renal cell carcinoma.
    Chen D; Li Y; Yu Z; Su Z; Yu W; Li Y; Yang S; Gui Y; Ni L; Lai Y
    Mol Med Rep; 2015 Jul; 12(1):1399-404. PubMed ID: 25815587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
    Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X
    Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
    Lin C; Li Z; Chen P; Quan J; Pan X; Zhao L; Zhou L; Lai Y; He T; Xu W; Xu J; Guan X; Li H; Yang S; Hu Y; Lai Y
    Life Sci; 2018 Sep; 209():481-489. PubMed ID: 30138594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma.
    Zhang WB; Pan ZQ; Yang QS; Zheng XM
    Ir J Med Sci; 2013 Dec; 182(4):621-7. PubMed ID: 23619562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1).
    Li Y; Quan J; Chen F; Pan X; Zhuang C; Xiong T; Zhuang C; Li J; Huang X; Ye J; Zhang F; Zhang Z; Gui Y
    Biomed Pharmacother; 2019 Mar; 111():517-526. PubMed ID: 30597305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
    BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.
    Zhang R; Zhang W; Xu B; Lv C; Hou J; Zhang G
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):695-702. PubMed ID: 32138544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of miR‑30b as an oncogene in renal cell carcinoma.
    Jin L; Li Y; He T; Hu J; Liu J; Chen M; Shi M; Jiang Z; Yang S; Mao X; Gui Y; Lai Y
    Mol Med Rep; 2017 Apr; 15(4):1837-1846. PubMed ID: 28259953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of miR-7 as an oncogene in renal cell carcinoma.
    Yu Z; Ni L; Chen D; Zhang Q; Su Z; Wang Y; Yu W; Wu X; Ye J; Yang S; Lai Y; Li X
    J Mol Histol; 2013 Dec; 44(6):669-77. PubMed ID: 23793934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer.
    Liu S; Wang Y; Li W; Yu S; Wen Z; Chen Z; Lin F
    Biomed Pharmacother; 2019 Nov; 119():109406. PubMed ID: 31514066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.